Enterococcus faecium SF68 Indications and Efficacy in Human

Enterococcus faecium SF68
Indications and Efficacy in Human
1. Acute Diarrhoea in Adults
Buydens, P. and S. Debeuckelaere. 1996. Efficacy of SF68 in the Treatment of
Acute Diarrhea. A Placebo-Controlled Trial. Scand J Gastroenterol. 31:887-891
Bruno, F. and G. Frigerio. 1981. Eine neuartige Möglichkeit zur Behandlung der
Enteritis - Kontrollierte Doppelblindversuche mit dem Stamm SF68. Schweiz.
Rundsch. Med. Prax.39:1717-1720.
*1)*2)
Camarri, E., A. Belvisi, G. Guidoni, G. Marini and G. Frigerio. 1981. A doubleblind comparison of two different treatments for acute enteritis in adults.
Chemotherapy. 27:466-470.
*1)
Lewenstein, A., G. Frigerio and M. Moroni. 1979. Biological properties of SF68, a
new approach for the treatment of diarrheal diseases. Curr. Ther. Res. 26:967-981.
2. Acute Diarrhoea in Children
Bellomo, G., C. Finocchiaro and G. Frigerio. 1979. Une nouvelle approche pour le
traitement des entérites en pédiatrie. Méd. et Hyg. 37:3781-3784.
*1)*2)
Bellomo, G., A. Mangiagli, L. Nicastro and G. Frigerio. 1980. A controlled doubleblind study of SF68 strain as a new biological preparation for the treatment of
diarrhoea in pediatrics. Curr. Ther. Res. 28:927-936.
D'Apuzzo, V. and R. Salzberg. 1982. Die Behandlung der akuten Diarrhö in der
Pädiatrie mit Streptococcus faecium: Resultate einer Doppelblindstudie. Ther.
Umsch. 39:1033-1035.
*1)*2)
3. Tourist’s Diarrhoea
Sparre-Linde, L. and L. Lindwall. 1986. The effect of Ventrux Acido (lactic acidforming bacteria) on tourist diarrhoea - a double blind study. Swed. J. Biol. Med.
3/86.
*3)
4. Dysbiosis due to Antibiotic Therapy
Alvisi, V. 1989. Antibioticoterapia-diarrea e disvitaminosi. Interviste d'attualità
Opinioni per il mondo medico. Suppl. 3/89.
Borgia, M., N. Sepe, V. Brancato and R. Borgia. 1982. A controlled clinical study
on Streptococcus faecium preparation for the prevention of side reactions during
long-term antibiotic treatments. Curr. Ther. Res. 31:265-271.
*1)
Marteau, P. R., M. de Vrese, C. J. Cellier and J. Schrezenmeir. 2001. Protection
from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73: 430S436S.
Wunderlich, P.F., L. Braun, I. Fumagalli, V. D'Apuzzo, F. Heim, M. Karly, R. Lodi,
G. Politta, F. Vonbank and L. Zeltner. 1989. Double-blind Report on the Efficacy of
Lactic Acid-producing Enterococcus SF68 in the Prevention of Antibiotic-associated
Diarrhoea and in the Treatment of Acute Diarrhoea. J.Int. Med. Res. 17:333-338.
Indications and Efficacy SF68 Human
2
5. Chronic Dysbiosis
Bruno, F., A. Nastasi and M. Bruno. 1983. Studio controllato doppio cieco
sull'effetto dell'enterococco lattoproduttore ceppo SF68 su manifestazioni associate a
forme enterocolitiche varie e a salmonellosi. Clin. Ter. 105:203-207.
Schiraldi, O., C. di Bari and F. Trotta. 1982. Le traitement par Streptococcus
faecium des porteurs asymptomatiques de Salmonelles. Méd. et Hyg. 40:445-446.
*1)*2)
6. Irritable Bowel Syndrom (IBS)
Lami, F. et al. 1982. Breath test evaluation of SF68 in IBS patients.Abstract from the
Symposium on Lactic Acid Bacteria - Pescara, Italy.
Lami, F. and C. Callegari. 1988. SF68 nella sindrome del colon irritabile: risultati.
Simposio Internazionale, Vienna.
Lami, F., C. Callegari, F. Levantesi, M. Tatali, R. Abbiati and L. Barbara. 1989.
Modificazioni indotte dalla somministrazione di Enterococcus faecium in pazienti con
sindrome del colon irritabile. Simposio Internazionale su Ecologia intestinale: dalla
microbiologia alla clinica, Sardegna. p. 77-82.
7. Hepatic Encephalopathy (HE)
Del Vecchio-Blanco, C., G. Ambrogio, D. Mattera and M. Coltorti. 1981. Influence
du traitement par Streptococcus faecium (SF68) sur la courbe ammoniémique de
charge protéique chez des sujets atteints de cirrhose hépatique. Méd. et Hyg.
39:2387-2389.
*1)*2)
Indications and Efficacy SF68 Human
3
Loguercio, C., C. Del Vecchio-Blanco and M. Coltorti. 1987. Enterococcus Lactic
Acid Bacteria Strain SF68 and Lactulose in Hepatic Encephalopathy: a Controlled
Study. J. Int. Med. Res.15:335-343.
Loguercio, C., R. Abbiati, M. Rinaldi, A. Romano, C. Del Vecchio Blanco and M.
Coltorti. 1995. Long-term effects of Enterococcus faecium SF68 versus lactulose in
in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.
Journal of Hepathology.23:39-46.
8. Further literature and reviews
Allen, S.J., B. Okoko, E. Martinez, G. Gregorio and L.F. Dans. 2004. Probiotics for
treating infectious diarrhoea. Cochrane Review. The Cochrane Library 2004, Issue 3.
Loizeau, D. 1994. Place de l’Entérocoque SF68 dans la prévention et le traitement
des gastro-entérites infectieuses et liées aux antibiotiques. Revue Médicale de la
Suisse Romande.114:651-654.
Salvioli, G., R. Salati, M. Bondi, A. Fratalocchi, B.M. Sala and A. Gibertini. 1982.
Bile Acid Transformation by the Intestinal Flora and Cholesterol Saturation in Bile.
Digestion. 23: 80-88.
*1)
*1)
*2)
*3)
Italian Version available (has been presented at the Symposium
of Pescara on 6th February 1982).
English translation available
Italian Version in "Interviste d'attualità Opinioni per il
mondo medico 1/89.
Indications and Efficacy SF68 Human
4